Anthony Cruz, B.S.

Summary

Anthony Cruz earned his B.S. in Molecular and Cellular Biology from Cornell University.  He continued his research with Dr. James Casey at Cornell College of Veterinary Medicine, looking at feline immunodeficiency virus pathogenesis.  Subsequently, Anthony worked with Dr. George Caughey in the Cardiovascular Research Institute (CVRI) at the University of California, San Francisco, and the San Francisco VA Hospital. There, he investigated the role of mast cell serine and metalloproteinases in the etiology of idiopathic pulmonary fibrosis and bronchiolitis obliterans.

At NIAMS, Anthony worked under Dr. Richard Siegel to decipher the role of TNF Superfamily members in autoimmune disease.  He studied the role of aberrant Fas-induced death signaling in Autoimmune Lymphoproliferative Syndrome (ALPS) and the novel costimulatory function of non-death Fas signaling, termed precocious differentiation.

Since 2018, Anthony has worked with Dr. Michael Ombrello, studying mechanisms of TNF Superfamily signaling in the development of Still’s Disease in young children (systemic juvenile idiopathic arthritis, sJIA).

Research Statement

Mr. Cruz is interested in how various forms of cell death contribute to the pathophysiology of autoimmune and autoinflammatory diseases.  Cell death has been a longstanding interest, starting in his undergraduate research looking at apoptosis in the viral pathogenesis of exotic strains of FIV.

For many years, he worked on the TNF Superfamily in various capacities, looking at the molecular and biochemical mechanisms that allow professional death receptors to take on alternative roles and how this contributes to immune cell homeostasis.

His current work involves investigating the potential role of TNF Superfamily members in the etiology of Still’s Disease.  

Scientific Publications

PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants.

Baysac K, Sun G, Nakano H, Schmitz EG, Cruz AC, Fisher C, Bailey AC, PLCG2-Immune Dysregulation Working Group, Mace E, Milner JD, Ombrello MJ
J Allergy Clin Immunol.
2024 Jan;
153(1).
doi: 10.1016/j.jaci.2023.08.036
PMID: 37769878

Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment.

Frazzette N, Cruz AC, Wu X, Hammer JA, Lippincott-Schwartz J, Siegel RM, Sengupta P
Cells.
2022 Jun 12;
11(12).
doi: 10.3390/cells11121908
PMID: 35741037

T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.

Yamamoto TN, Lee PH, Vodnala SK, Gurusamy D, Kishton RJ, Yu Z, Eidizadeh A, Eil R, Fioravanti J, Gattinoni L, Kochenderfer JN, Fry TJ, Aksoy BA, Hammerbacher JE, Cruz AC, Siegel RM, Restifo NP, Klebanoff CA
J Clin Invest.
2019 Feb 25;
129(4).
doi: 10.1172/JCI121491
PMID: 30694219

Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction.

Cruz AC, Ramaswamy M, Ouyang C, Klebanoff CA, Sengupta P, Yamamoto TN, Meylan F, Thomas SK, Richoz N, Eil R, Price S, Casellas R, Rao VK, Lippincott-Schwartz J, Restifo NP, Siegel RM
Nat Commun.
2016 Dec 23;
7().
doi: 10.1038/ncomms13895
PMID: 28008916

Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor.

Fu Q, Fu TM, Cruz AC, Sengupta P, Thomas SK, Wang S, Siegel RM, Wu H, Chou JJ
Mol Cell.
2016 Feb 18;
61(4).
doi: 10.1016/j.molcel.2016.01.009
PMID: 26853147

Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.

Klebanoff CA, Scott CD, Leonardi AJ, Yamamoto TN, Cruz AC, Ouyang C, Ramaswamy M, Roychoudhuri R, Ji Y, Eil RL, Sukumar M, Crompton JG, Palmer DC, Borman ZA, Clever D, Thomas SK, Patel S, Yu Z, Muranski P, Liu H, Wang E, Marincola FM, Gros A, Gattinoni L, Rosenberg SA, Siegel RM, Restifo NP
J Clin Invest.
2016 Jan;
126(1).
doi: 10.1172/JCI81217
PMID: 26657860

Education

Cornell University 
B.S. in Molecular and Cellular Biology (2000)

Experience

Research Scientist 
University of California, San Francisco (2000-2006) 

Research Biologist 
NIH, NIAMS (2006-2016) 

Senior Research Biologist
NIH, NIAMS (2016-present)

Last Updated: